Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Isis pharmaceuticals, inc. – product pipeline review – 2012


Published on

2012 | | Isis pharmaceuticals, inc. – product pipeline review – 2012

Published in: Business
  • Be the first to comment

  • Be the first to like this

Isis pharmaceuticals, inc. – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Isis Pharmaceuticals, Inc. – Product Pipeline Review – 2012 You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s pharmaceuticals report, “Isis Pharmaceuticals, Inc. - ProductPipeline Review - 2012” provides data on the Isis Pharmaceuticals, Inc.’s researchand development focus. The report includes information on current developmentalpipeline, complete with latest updates, and features on discontinued and dormantprojects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Isis Pharmaceuticals, Inc.’s corporate website, SEC filings,investor presentations and featured press releases, both from Isis Pharmaceuticals,Inc. and industry-specific third party sources, put together by Global MarketsDirect’s team.Scope- Isis Pharmaceuticals, Inc. - Brief Isis Pharmaceuticals, Inc. overview includingbusiness description, key information and facts, and its locations and subsidiaries.- Review of current pipeline of Isis Pharmaceuticals, Inc. human therapeuticdivision.- Overview of pipeline therapeutics across various therapy areas.Reasons to buy
  2. 2. - Evaluate Isis Pharmaceuticals, Inc.’s strategic position with total access to detailedinformation on its product pipeline.- Assess the growth potential of Isis Pharmaceuticals, Inc. in its therapy areas offocus.- Identify new drug targets and therapeutic classes in the Isis Pharmaceuticals, Inc.’sR&D portfolio and develop key strategic initiatives to reinforce pipeline in thoseareas.Table of contents:List of Tables 6List of Figures 7Isis Pharmaceuticals, Inc. Snapshot 8Isis Pharmaceuticals, Inc. Overview 8Key Information 8Key Facts 8Isis Pharmaceuticals, Inc. – Research and Development Overview 9Key Therapeutic Areas 9Isis Pharmaceuticals, Inc. – Pipeline Review 12Pipeline Products by Stage of Development 12Pipeline Products – Monotherapy 13Pipeline Products – Combination Treatment Modalities 14Isis Pharmaceuticals, Inc. – Pipeline Products Glance 15Isis Pharmaceuticals, Inc. Clinical Stage Pipeline Products 15Phase II Products/Combination Treatment Modalities 15Phase I Products/Combination Treatment Modalities 16Isis Pharmaceuticals, Inc. – Early Stage Pipeline Products 17Pre-Clinical Products/Combination Treatment Modalities 17Isis Pharmaceuticals, Inc. – Drug Profiles 18ISIS 113715 18Product Description 18Mechanism of Action 18R&D Progress 18ISIS-APOA 20Product Description 20Mechanism of Action 20
  3. 3. List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview – 2012&PubId=&pagenum=1HanAll Biopharma Co., Ltd. – Product Pipeline Review – 2012Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012IntelGenx Corp. – Product Pipeline Review – 2012Isis Pharmaceuticals, Inc. – Product Pipeline Review – 2012JADO Technologies GmbH – Product Pipeline Review – 2012Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2012NeuroSearch A/S – Product Pipeline Review – 2012NovaDel Pharma, Inc. – Product Pipeline Review – 2012Portola Pharmaceuticals, Inc. – Product Pipeline Review – 2012
  4. 4. Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: